Details for New Drug Application (NDA): 050592
✉ Email this page to a colleague
The generic ingredient in TOBRADEX is dexamethasone; tobramycin. There are thirty-nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dexamethasone; tobramycin profile page.
Summary for 050592
Tradename: | TOBRADEX |
Applicant: | Sandoz |
Ingredient: | dexamethasone; tobramycin |
Patents: | 0 |
Pharmacology for NDA: 050592
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 050592
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TOBRADEX | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050592 | NDA | Novartis Pharmaceuticals Corporation | 0078-0953 | 0078-0953-25 | 5 mL in 1 BOTTLE (0078-0953-25) |
TOBRADEX | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050592 | NDA | Novartis Pharmaceuticals Corporation | 0078-0953 | 0078-0953-26 | 10 mL in 1 BOTTLE (0078-0953-26) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION/DROPS;OPHTHALMIC | Strength | 0.1%;0.3% | ||||
Approval Date: | Aug 18, 1988 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 050592
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | TOBRADEX | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050592-001 | Aug 18, 1988 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription